SlideShare a Scribd company logo
Pesticide
1
Nut Sangjumrus, 3 rd year resident
Occupational medicine, KKU
2
3
1.Paraquat
2.Glyphosate
3.Chlorpyrifos
4
794.5M
http://www.doa.go.th/ard/wp-content/uploads/2020/01/HASTAT62_01รายงานสรุปการนำเข้าวัตถุอันตรายทางการเกษตร-ปี-พ.ศ.-๒๕๖๑-รายละเอียด-.pdf 5
http://www.doa.go.th/ard/wp-content/uploads/2020/02/HASTAT62_03.pdf 6
CONTENT
1. What is pesticide ?
2. Type of pesticide
• Paraquat
• Glyphosate
• Chlorpyrifos
3. Medical surveillance of OPCM
4. Related law
7
1.WHATISPESTICIDE???
8
1.WHATISPESTICIDE???
9
1.WHATISPESTICIDE???
10
• insecticides,
• herbicides,
• rodenticides,
• fungicides.
2.TYPEOFPESTICIDE
WELL KNOWN PESTICIDE
• algicides
• fumigants
• ovicides
LESS KNOWN PESTICIDE
11
2.TYPEOFPESTICIDE
http://envocc.ddc.moph.go.th/contents/view/106 12
2.TYPEOFPESTICIDE
http://envocc.ddc.moph.go.th/contents/view/106 13
PARAQUAT
GLYPHOSATE
CHLORPYRIFOS
(INSECTICIDE)
(HERBICIDE)
(HERBICIDE)
14
PARAQUAT
15
HEALTH EFFECT
PARAQUAT
MILD TOXICITY MODERATE TOXICITY SEVERE TOXICITY
https://webwiser.nlm.nih.gov/substance?substanceId=528&identifier=Paraquat&identifierType=name&menuItemId=62&catId=83 16
HEALTH EFFECT
PARAQUAT
MILD TOXICITY
https://webwiser.nlm.nih.gov/substance?substanceId=528&identifier=Paraquat&identifierType=name&menuItemId=62&catId=83 17
CAUSTIC INJURY TO THE ORAL
MUCOSA AND ESOPHAGUS.
NAUSEA AND VOMITING
ARE COMMON.
SYMPTOMS USUALLY
RESOLVE IN PATIENTS
WITH A MILD EXPOSURE.
MILD TOXICITY: Ingestion of less than 20 mg paraquat ion
per kg body weight (less than 7.5 mL of 20% [w/v]
paraquat concentrate): No symptoms or mild GI effects
HEALTH EFFECT
PARAQUAT
MODERATE
TOXICITY
THE PATIENT MAY DEVELOP
TRANSIENT RENAL, HEPATIC
AND RESPIRATORY
IMPAIRMENT.
https://webwiser.nlm.nih.gov/substance?substanceId=528&identifier=Paraquat&identifierType=name&menuItemId=62&catId=83 18
PATIENTS WITH MODERATE
TOXICITY CAN DEVELOP
PERMANENT PULMONARY
INJURY.
MODERATE to SEVERE TOXICITY: 20 to 40 mg paraquat ion per kg body weight
(7.5 to 15 mL of 20% [w/v] paraquat concentrate): Pulmonary fibroplasia develops.
Death occurs in most cases, but may be delayed 2 to 3 weeks.
HEALTH EFFECT
PARAQUAT
https://webwiser.nlm.nih.gov/substance?substanceId=528&identifier=Paraquat&identifierType=name&menuItemId=62&catId=83 19
SEVERE TOXICITY
FATAL: Greater than 40 mg paraquat ion per kg body weight (more than 15 mL of
20% [w/v] paraquat concentrate): Multiple organ failure occurs; toxicity progresses
rapidly. Mortality is essentially 100% in 1 to 7 days.
SEVERE PARAQUAT TOXICITY HAVE INGESTED
CONCENTRATED FORMS OF THE HERBICIDE.
PATIENTS MAY DIE IN THE FIRST SEVERAL DAYS DUE
TO GASTROINTESTINAL PERFORATIONS OR
MULTIORGAN FAILURE.
PATIENTS THAT SURVIVE THE EARLY PHASE OF
TOXICITY INVOLVING CARDIOVASCULAR, HEPATIC,
AND RENAL SYSTEMS DEVELOP PULMONARY
FIBROSIS AND SUBSEQUENT DEATH OVER THE
FOLLOWING 2 TO 4 WEEKS POSTINGESTION.• 3) EARLY FINDINGS may include:
Chronic effect
• increased risk of parkinson disease ?
• cellulitis ,NF ?
PARAQUAT
HEALTH EFFECT
20
• Pre-employment and annual medical examinations should be made available to all
persons who are regularly exposed to paraquat at potentially hazardous levels.
• Attention should be given to all normal parameters of overall health status, with
particular attention to the state of the skin and of pulmonary function. [1]
• There is no direct evidence that paraquat is a human carcinogen.[2]
PARAQUAT
[1] http://www.inchem.org/documents/hsg/hsg/hsg051.htm#PartNumber:4
[2] https://webwiser.nlm.nih.gov/substance?substanceId=528&identifier=Paraquat&identifierType=name&menuItemId=62&catId=83
21
• Plasma paraquat level
• Urine alkaline dithionite test
LABORATORYTESTING
FOR PARAQUAT
https://med.mahidol.ac.th/poisoncenter/sites/default/files/public/pdf/books/Pesticide_book-05_Paraquat.pdf
22
GLYPHOSATE
23
https://www.eenews.net/stories/1060332679
https://www.bbc.com/news/world-us-canada-45152546?SThisFB&fbclid=IwAR1x1voFFx9mFFyGCeNYATqP69Novl7NFTWBWjFRUVLcLlmmx0-VVGX7E_0#
24
Health effects
GLYPHOSATE
increased risk of
autism?
skin and
gastrointestinal
irritation
https://med.mahidol.ac.th/poisoncenter/sites/default/files/public/pdf/books/Pesticide_book-06_Glyphosate.pdf
Carcinogenicity :
IARC 2A
In March 2015, (IARC) announced that
glyphosate probably caused a type of cancer
called non-Hodgkin’s lymphoma.
https://gmb.org.uk/sites/default/files/HS_Glyphosate.pdf
https://www.iarc.fr/wp-content/uploads/2018/11/QA_Glyphosate.pdf
25
• Blood glyphosate
LABORATORYTESTING
FOR GLYPHOSATE
https://med.mahidol.ac.th/poisoncenter/sites/default/files/public/pdf/books/Pesticide_book-06_Glyphosate.pdf
26
CHLORPYRIFOS
27
• Nicotinic symptom
• Muscarinic symptom
• Intermediate syndrome
• OPDIP (OP-induced delayed
polyneuropathy)
ORGANOPHOSPHATE
Health effects
https://creativemeddoses.com/topics-list/organophosphate-poisoning/
28
Mechanism
https://creativemeddoses.com/topics-list/organophosphate-poisoning/
ORGANOPHOSPHATE
https://creativemeddoses.com/topics-list/organophosphate-poisoning/
29
• Urine alkyl phosphate metabolite test
• Plasma cholinesterase level
• RBC cholinesterase level
LABORATORYTESTING
FOR ORGANOPHOSPHATE
https://med.mahidol.ac.th/poisoncenter/sites/default/files/public/pdf/books/Pesticide_book-06_Glyphosate.pdf
30
31
ACGIH 2020 32
True baseline is recommended !!!
Medical surveillance
ORGANOPHOSPHATE
33
• History
• Physical examination
• Investigation
http://envocc.ddc.moph.go.th/uploads/31858/1-56.pdf
นบก 1-56 ของ กองโรคจากการประกอบอาชีพ
Nicotinic, Muscarinic overstimulation
Cholinesterase level (RBC, plasma)
Urine alkyl phosphate metabolite test
Medical surveillance
ORGANOPHOSPHATE
• working baseline
• true baseline
• medical removal protection
• return to work level
34
Medical surveillance
ORGANOPHOSPHATE
OSHA DOSH
Who to monitor?
• Individuals who apply Class I or II OP*
• Working 30 or more hours within any
30-day period
Any occupational exposure to OP.
What to measure?
both acetylcholinesterase and butyryl
cholinesterase
Plasma cholinesterase estimation is good
enough for medical surveillance.
However for treatment purposes, Red blood
cell cholinesterase estimation
* https://www.who.int/ipcs/publications/pesticides_hazard_rev_3.pdf 35
Medical surveillance
ORGANOPHOSPHATE
OSHA DOSH
action level
medical removal
protection
Medical Removal
>30% decrease in AchE
or
>40% decrease in PChE
1.plasma ACHE or rbc ACHE of less
than 50% of the pre-employment or
laboratory's normal level.
2.rbc ACHE of between 50 and 70%
of the pre-employment level showing
a fall of more than 10% in their repeat
test results.
evaluation workplace
>20% decrease from baseline in
AChE or PChE 
-
36
Medical surveillance
ORGANOPHOSPHATE
OSHA DOSH
return to work
***Retest for Return to Work
• Days to repeat test is determined by degree
of ChE activity reduction.
• RBC: (% depression - 20) /0.83 = # of days
to repeat test
• plasma: (% depression - 20) / 1.2 = # of
days to repeat test
Return to work when test result is  greater
than or equal to  80% of baseline.
All suspended cases should have
repeat plasma ACHE estimations at
monthly intervals.
The worker may return to work with OP
and/or CM when the plasma ACHE has
returned to more than 70% of the pre-
employment level.
37
RELATEDLAW
38
39
40
41
42
43
44
45
• สารที่ขึ้นเป็นวัตถุอันตราย วอ.4 ได้แก่ paraquat and chlorpyrifos
• plasma-ChE มีความจำเพาะน้อยกว่า RBC-ChE
TAKEHOMEMESSAGE
OSHA DOSH
action level
medical removal
protection
Medical Removal
>30% decrease in AchE
or
>40% decrease in PChE
1.plasma ACHE or rbc ACHE of less than 50%
of the pre-employment or laboratory's
normal level.
2.rbc ACHE of between 50 and 70% of the
pre-employment level showing a fall of more
than 10% in their repeat test results.
evaluation workplace >20% decrease from baseline in AChE or PChE  -
RTW
Return to work when test result is  greater than or equal
to  80% of baseline.
The worker may return to work with OP and/or
CM when the plasma ACHE has returned to
more than 70% of the pre-employment level.
46
-PARACELSUS
47
“ALLTHINGSAREPOISONS,FORTHEREISNOTHINGWITHOUT
POISONOUSQUALITIES.
ITISONLYTHEDOSEWHICHMAKESATHINGPOISON.”
THANKSFORATTENTION

More Related Content

What's hot

infection and inflammation. adult health
infection and inflammation. adult healthinfection and inflammation. adult health
infection and inflammation. adult health
DishaThakur53
 

What's hot (20)

RESPIRATORY SYSTEM: PATHOLOGY OF PNEUMONIAS
RESPIRATORY SYSTEM: PATHOLOGY OF PNEUMONIASRESPIRATORY SYSTEM: PATHOLOGY OF PNEUMONIAS
RESPIRATORY SYSTEM: PATHOLOGY OF PNEUMONIAS
 
Diphtheria
DiphtheriaDiphtheria
Diphtheria
 
Empysema
EmpysemaEmpysema
Empysema
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Mamb 1112 1.1 pengenalan mikrobiologi
Mamb 1112 1.1 pengenalan mikrobiologiMamb 1112 1.1 pengenalan mikrobiologi
Mamb 1112 1.1 pengenalan mikrobiologi
 
ASPHYXIA.pptx
ASPHYXIA.pptxASPHYXIA.pptx
ASPHYXIA.pptx
 
A short guide to scabies treatment 2016
A short guide to scabies treatment  2016A short guide to scabies treatment  2016
A short guide to scabies treatment 2016
 
Anthrax ppt deepa
Anthrax ppt deepaAnthrax ppt deepa
Anthrax ppt deepa
 
1592880638275 insulin injection technique
1592880638275 insulin injection technique1592880638275 insulin injection technique
1592880638275 insulin injection technique
 
Death
DeathDeath
Death
 
Infanticide
InfanticideInfanticide
Infanticide
 
infection and inflammation. adult health
infection and inflammation. adult healthinfection and inflammation. adult health
infection and inflammation. adult health
 
Occupational lung disease
Occupational lung diseaseOccupational lung disease
Occupational lung disease
 
Influenza
InfluenzaInfluenza
Influenza
 
Chain of infection
Chain of infectionChain of infection
Chain of infection
 
Swine Flu Final
Swine Flu FinalSwine Flu Final
Swine Flu Final
 
Silicosis
SilicosisSilicosis
Silicosis
 
Larva migrans
Larva migransLarva migrans
Larva migrans
 
Notes on forensic medicines
Notes on forensic medicinesNotes on forensic medicines
Notes on forensic medicines
 
COPD
COPDCOPD
COPD
 

Similar to Pesticide in Thailand

Novel treatments to trigger final follicular maturation and luteal phase support
Novel treatments to trigger final follicular maturation and luteal phase supportNovel treatments to trigger final follicular maturation and luteal phase support
Novel treatments to trigger final follicular maturation and luteal phase support
Sandro Esteves
 
IAEA-2014-CanpingPAN01
IAEA-2014-CanpingPAN01IAEA-2014-CanpingPAN01
IAEA-2014-CanpingPAN01
Canping Pan
 

Similar to Pesticide in Thailand (20)

Career in pharmacy
Career in pharmacyCareer in pharmacy
Career in pharmacy
 
Generation of false positive sars co v-2 antigen results with testing conditi...
Generation of false positive sars co v-2 antigen results with testing conditi...Generation of false positive sars co v-2 antigen results with testing conditi...
Generation of false positive sars co v-2 antigen results with testing conditi...
 
ICH Q3C GUIDELINE
ICH Q3C GUIDELINEICH Q3C GUIDELINE
ICH Q3C GUIDELINE
 
Radiopharmaceuticals from a regulatory perspective
Radiopharmaceuticals from a regulatory perspectiveRadiopharmaceuticals from a regulatory perspective
Radiopharmaceuticals from a regulatory perspective
 
ICH [ Q ] Guidelines
ICH [ Q ] GuidelinesICH [ Q ] Guidelines
ICH [ Q ] Guidelines
 
Tiêu chuẩn GMP WHO cho các hoạt chất dược dụng
Tiêu chuẩn GMP WHO cho các hoạt chất dược dụngTiêu chuẩn GMP WHO cho các hoạt chất dược dụng
Tiêu chuẩn GMP WHO cho các hoạt chất dược dụng
 
Impurity of drug Subatances.pptx
Impurity of drug Subatances.pptxImpurity of drug Subatances.pptx
Impurity of drug Subatances.pptx
 
Mechanistic Oral Absorption Modelling, An update on cross-industry activities
Mechanistic Oral Absorption Modelling, An update on cross-industry activitiesMechanistic Oral Absorption Modelling, An update on cross-industry activities
Mechanistic Oral Absorption Modelling, An update on cross-industry activities
 
Clinical Research, pharmacy,
Clinical Research, pharmacy, Clinical Research, pharmacy,
Clinical Research, pharmacy,
 
Pharmaceutical Market Aspects and Audits of Ethiopia
Pharmaceutical Market Aspects and Audits of EthiopiaPharmaceutical Market Aspects and Audits of Ethiopia
Pharmaceutical Market Aspects and Audits of Ethiopia
 
cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]
 
Analysis of raw material and finished product
Analysis of raw material and finished productAnalysis of raw material and finished product
Analysis of raw material and finished product
 
DRUG DISCOVERY &DEVELOPMENT.ppt
DRUG DISCOVERY &DEVELOPMENT.pptDRUG DISCOVERY &DEVELOPMENT.ppt
DRUG DISCOVERY &DEVELOPMENT.ppt
 
Introduction to Pharmaceuticak Industry.pptx
Introduction to Pharmaceuticak Industry.pptxIntroduction to Pharmaceuticak Industry.pptx
Introduction to Pharmaceuticak Industry.pptx
 
Q3A(R2)
Q3A(R2)Q3A(R2)
Q3A(R2)
 
Novel treatments to trigger final follicular maturation and luteal phase support
Novel treatments to trigger final follicular maturation and luteal phase supportNovel treatments to trigger final follicular maturation and luteal phase support
Novel treatments to trigger final follicular maturation and luteal phase support
 
Impurities in Drug Synthesis
Impurities in Drug SynthesisImpurities in Drug Synthesis
Impurities in Drug Synthesis
 
Dcgi adverse event
Dcgi adverse eventDcgi adverse event
Dcgi adverse event
 
IAEA-2014-CanpingPAN01
IAEA-2014-CanpingPAN01IAEA-2014-CanpingPAN01
IAEA-2014-CanpingPAN01
 
ICH GUIDELINE Q 23024671010_RA.pptx
ICH GUIDELINE Q      23024671010_RA.pptxICH GUIDELINE Q      23024671010_RA.pptx
ICH GUIDELINE Q 23024671010_RA.pptx
 

Recently uploaded

Advanced Gum Health prebiotic Mints.pptx
Advanced Gum Health prebiotic Mints.pptxAdvanced Gum Health prebiotic Mints.pptx
Advanced Gum Health prebiotic Mints.pptx
Dentulu Inc
 
Immunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentationImmunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentation
BeshedaWedajo
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
SasikiranMarri
 
Integrated Mother and Neonate Childwood Illness Health Care
Integrated Mother and Neonate Childwood Illness  Health CareIntegrated Mother and Neonate Childwood Illness  Health Care
Integrated Mother and Neonate Childwood Illness Health Care
ASKatoch1
 

Recently uploaded (20)

The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
 
Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤
Dehradun ❤CALL Girls  8901183002 ❤ℂall  Girls IN Dehradun ESCORT SERVICE❤Dehradun ❤CALL Girls  8901183002 ❤ℂall  Girls IN Dehradun ESCORT SERVICE❤
Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤
 
Ayurveda hair cosmetlogy on Indralupta or Alopecia.pptx
Ayurveda hair cosmetlogy on Indralupta or Alopecia.pptxAyurveda hair cosmetlogy on Indralupta or Alopecia.pptx
Ayurveda hair cosmetlogy on Indralupta or Alopecia.pptx
 
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdf
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdfCHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdf
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdf
 
Management of psoriasis.pptx (Recent advances)
Management of psoriasis.pptx (Recent advances)Management of psoriasis.pptx (Recent advances)
Management of psoriasis.pptx (Recent advances)
 
Advanced Gum Health prebiotic Mints.pptx
Advanced Gum Health prebiotic Mints.pptxAdvanced Gum Health prebiotic Mints.pptx
Advanced Gum Health prebiotic Mints.pptx
 
Deepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptxDeepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptx
 
Enhancing-Patient-Centric-Clinical-Trials.pdf
Enhancing-Patient-Centric-Clinical-Trials.pdfEnhancing-Patient-Centric-Clinical-Trials.pdf
Enhancing-Patient-Centric-Clinical-Trials.pdf
 
Immunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentationImmunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentation
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
Unlocking the Benefits of Cognitive Behavioural Therapy (CBT) with Renewed Edge
Unlocking the Benefits of Cognitive Behavioural Therapy (CBT) with Renewed EdgeUnlocking the Benefits of Cognitive Behavioural Therapy (CBT) with Renewed Edge
Unlocking the Benefits of Cognitive Behavioural Therapy (CBT) with Renewed Edge
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
Integrated Mother and Neonate Childwood Illness Health Care
Integrated Mother and Neonate Childwood Illness  Health CareIntegrated Mother and Neonate Childwood Illness  Health Care
Integrated Mother and Neonate Childwood Illness Health Care
 
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdfCHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
 
QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020
 
Storage_of _Bariquin_Components_in_Storage_Boxes.pptx
Storage_of _Bariquin_Components_in_Storage_Boxes.pptxStorage_of _Bariquin_Components_in_Storage_Boxes.pptx
Storage_of _Bariquin_Components_in_Storage_Boxes.pptx
 

Pesticide in Thailand